RAPT Therapeutics
$28.759876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$28.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.54 (+1.91%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell RAPT and other stocks, options, ETFs, and crypto commission-free!
About RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. Read More The company was founded in 2015 and is headquartered in South San Francisco, CA. The listed name for RAPT is RAPT Therapeutics, Inc. Common Stock.
Employees
67
Headquarters
South San Francisco, California
Founded
2015
Market Cap
703.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
351.61K
High Today
$29.36
Low Today
$27.80
Open Price
$28.22
Volume
106.27K
52 Week High
$51.21
52 Week Low
$10.52
Collections
RAPT Earnings
-$12.41
-$8.27
-$4.14
$0.00
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 21, Pre-Market